BOCA RATON, Fla., Oct. 14, 2021 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the ...
Salix announced the completion and outcome of two Phase 3 studies evaluating the efficacy and safety of budesonide foam in the treatment of active mild to moderate ulcerative proctitis (UP) or ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio New data showed similar clinical and ...
BEVERLY, MA--(Marketwired - Jan 26, 2015) - Cellceutix Corporation (OTC: CTIX) (the "Company"), a clinical stage biopharmaceutical company developing innovative therapies with oncology, dermatology ...
BEVERLY, MA--(Marketwired - June 15, 2016) - Cellceutix Corporation (CTIX) (the "Company"), a clinical stage biopharmaceutical company developing innovative therapies with oncology, dermatology, ...
<0> Salix Pharmaceuticals, Ltd.Adam C. DerbyshireExecutive Vice President and Chief Financial OfficerorG. Michael FreemanAssociate Vice President, Investor Relations and Corporate ...
Once remission has been achieved, however, there is no evidence that steroid enemas will maintain the remission. [27] Thus with the risk of cumulative systemic absorption of topically administered ...
Canasa (mesalamine) is a brand-name suppository that’s prescribed for ulcerative proctitis in adults. As with other drugs, Canasa can cause side effects, such as dizziness and rectal pain. Canasa can ...
Hosted on MSN
Do You Know the Different Types of UC?
Ulcerative colitis (UC), a type of inflammatory bowel disease (IBD) in which the lining of the colon becomes inflamed, causes symptoms that include urgent bowel movements, bloody stools, and cramping.
BOCA RATON, Fla., Sept. 28, 2021 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First Wave BioPharma”, “First Wave”, or the “Company ...
Previous Phase 1b clinical data suggest niclosamide delivers favorable efficacy compared to topical corticosteroid in the treatment of ulcerative proctitis and ulcerative proctosigmoiditis BOCA RATON, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback